CAR T Cells Encouraging for Diffuse Large B-Cell Lymphoma – Medscape
Medscape |
CAR T Cells Encouraging for Diffuse Large B-Cell Lymphoma
Medscape MADRID — Two investigational chimeric antigen receptor (CAR) modified T–cell therapies, both targeting CD19, have shown encouraging response rates in the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL), with adverse events … |
